BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9039340)

  • 1. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
    Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
    Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression and normal nucleotide sequence of androgen receptor gene coding and promoter regions in a family with partial androgen insensitivity syndrome.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Hurley DM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):281-8. PubMed ID: 9156036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.
    Liu Q; Yin X; Li P
    Reprod Biol Endocrinol; 2020 Apr; 18(1):34. PubMed ID: 32345305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.
    Batch JA; Williams DM; Davies HR; Brown BD; Evans BA; Hughes IA; Patterson MN
    Hum Mol Genet; 1992 Oct; 1(7):497-503. PubMed ID: 1307250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
    Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity.
    Akcay T; Fernandez-Cancio M; Turan S; Güran T; Audi L; Bereket A
    Andrology; 2014 Jul; 2(4):572-8. PubMed ID: 24737579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
    Radmayr C; Culig Z; Hobisch A; Corvin S; Bartsch G; Klocker H
    Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene.
    Davies HR; Hughes IA; Patterson MN
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):69-77. PubMed ID: 7641413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.
    Brown TR; Migeon CJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):542-50. PubMed ID: 3944238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.
    Brown TR; Lubahn DB; Wilson EM; French FS; Migeon CJ; Corden JL
    Mol Endocrinol; 1990 Dec; 4(12):1759-72. PubMed ID: 2082179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.
    Tincello DG; Saunders PT; Hodgins MB; Simpson NB; Edwards CR; Hargreaves TB; Wu FC
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Chávez B; Méndez JP; Ulloa-Aguirre A; Larrea F; Vilchis F
    J Hum Genet; 2001; 46(10):560-5. PubMed ID: 11587068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.